The US-EU pharma tariff cap has been finalized at 15%, impacting manufacturing, supply chain, and quality and promoting ...

By 2026, the updates to Chapter 4 and Annex 11, along with the introduction of Annex 22, will bring about a significant ...

FDA announced on Aug. 19, 2025 that B. Braun Medical has recalled two lots of its Lactated Ringers Injection, USP, 1000 mL and 0.9% Sodium Chloride Injection, USP, 1000 mL, distributed nationwide up ...

The company will be adding a 160,000-square-foot dedicated manufacturing facility at the FUJIFILM site in Holly Springs, NC.

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost ...

FDA’s recommendation to control 7-OH products under the Controlled Substances Act should help prevent competition between ...

Orlynvah is the first new, branded product for the treatment of uncomplicated UTIs to be introduced in the US in more than 25 years.

Based on an analysis done by the European Medicines Agency on the feasibility of alternatives, the European Commission ...

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...

The company will highlight how its GMP services combine engineering, consulting, equipment qualification, and facility ...

Dave Miller, PhD, discusses how shifting drug manufacturing to domestic CDMOs can improve quality, reduce rework, and enhance ...

The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...